Combination of bevacizumab plus irinotecan in recurrent malignant gliomas (MG): A retrospective study of efficacy and safety

被引：0
|
作者：
Gil Gil, M. J., Sr.
Martinez-Garcia, M.
Reynes, G.
Costas, E.
Fernandez-Chacon, C.
Pernas, S.
Benavides, M.
Herrero, A.
Perez-Martin, J.
Balana, C.
机构：
[1] Inst Catala Oncol, Barcelona, Spain
[2] Hosp Univ La Fe, Valencia, Spain
[3] MD Anderson Espana Int, Madrid, Spain
[4] Hosp Carlos Haya, Malaga, Spain
[5] Hosp Miguel Servet, Zaragoza, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13011
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Retrospective study of bevacizumab for recurrent malignant gliomas and analysis of the patterns of recurrence
    Norden, Andrew D.
    Young, Geoffrey
    Setayesh, Kian
    Muzikansky, Alona
    Klufas, Roman
    Ross, Gina
    Drappatz, Jan
    Kesari, Santosh
    Ciampa, Abigail Slate
    Ebbeling, Laura G.
    Levy, Brenda
    Wen, Patrick
    NEURO-ONCOLOGY, 2007, 9 (04) : 515 - 516
  • [22] SALVAGE CONCURRENT CHEMOTHERAPY WITH BEVACIZUMAB FOR RECURRENT MALIGNANT GLIOMAS PREVIOUSLY TREATED WITH BEVACIZUMAB AND IRINOTECAN
    Torcuator, Roy
    Zuniga, Richard
    Doyle, Thomas
    Anderson, Joseph
    Mikkelsen, Tom
    NEURO-ONCOLOGY, 2008, 10 (05) : 829 - 829
  • [23] SAFETY ANALYSIS OF BEVACIZUMAB PLUS NOVOTTF-100A IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS
    Elzinga, Grace
    Chung, Amy
    Wong, Eric T.
    NEURO-ONCOLOGY, 2013, 15 : 134 - 134
  • [24] Safety analysis of bevacizumab plus NovoTTF-100A in patients with recurrent malignant gliomas
    Elzinga, Grace
    Chung, Amy T.
    Wong, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Efficacy of bevacizumab plus irinotecan in children with recurrent Low-grade gliomas-a Pediatric Brain Tumor Consortium study
    Gururangan, Sridharan
    Fangusaro, Jason
    Poussaint, Tina Young
    McLendon, Roger E.
    Onar-Thomas, Arzu
    Wu, Shengjie
    Packer, Roger J.
    Banerjee, Anu
    Gilbertson, Richard J.
    Fahey, Frederic
    Vajapeyam, Sridhar
    Jakacki, Regina
    Gajjar, Amar
    Goldman, Stewart
    Pollack, Ian F.
    Friedman, Henry S.
    Boyett, James M.
    Fouladi, Maryam
    Kun, Larry E.
    NEURO-ONCOLOGY, 2014, 16 (02) : 310 - 317
  • [26] Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study
    Bai, Xuexue
    Xing, Hao
    Feng, Ming
    Ma, Wenbin
    Wang, Shiyong
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1617 - 1626
  • [27] Bevacizumab and irinotecan is an effective treatment for malignant gliomas
    Vredenburgh, James
    Desjardins, Annick
    Herndon, James E., II
    Reardon, David
    Quinn, Jennifer
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Friedman, Allan
    Bigner, Darell
    Friedman, Henry
    NEURO-ONCOLOGY, 2006, 8 (04) : 454 - 454
  • [28] Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
    Norden, A. D.
    Young, G. S.
    Setayesh, K.
    Muzikansky, A.
    Klufas, R.
    Ross, G. L.
    Ciampa, A. S.
    Ebbeling, L. G.
    Levy, B.
    Drappatz, J.
    Kesari, S.
    Wen, P. Y.
    NEUROLOGY, 2008, 70 (10) : 779 - 787
  • [29] Bevacizumab plus irinotecan in recurrent glioblastoma
    Chamberlain, Marc C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 1012 - 1013
  • [30] EFFICACY AND SAFETY OF BEVACIZUMAB (BV) AND IRINOTECAN (I) IN ELDERLY PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORM (GBM): A MONOCENTRIC RETROSPECTIVE STUDY
    Robert, M.
    Leux, C.
    Gourmelon, C.
    Campone, M.
    Frenel, J.
    ANNALS OF ONCOLOGY, 2014, 25
12345